NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Grant Opportunity Analysis
The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, is accepting applications for investigator-initiated, milestone-driven clinical trials to advance research in infectious, allergic, and immunologic diseases. Funded projects must implement a single clinical trial that is ready to begin rather than planning activities, and may include integrated mechanistic studies to promote the understanding of human diseases. Applications require a complete clinical protocol alongside detailed data and safety monitoring plans, with cooperative agreements supporting standard trials up to 5 years or complex projects for 6 to 7 years. The deadline for applications under this funding opportunity is July 5, 2029, and inquiries can be directed to NIAID_IICT_U01@mail.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.